Gottenberg, J., Chaudier, A., Allenbach, Y., Mekinian, A., Amoura, Z., Cacoub, P., Cornec, D., Hachulla, E., Quartier, P., Melki, I., Richez, C., Seror, R., Terrier, B., Devauchelle-Pensec, V., Henry, J., Gatfosse, M., Bouillet, L., Gaigneux, E., Andre, V., Baulier, G., Saunier, A., Desmurs, M., Poulet, A., Ete, M., Bienvenu, B., Truchetet, M., Michaud, M., Larroche, C., Dellal, A., Leurs, A., Ottaviani, S., Nielly, H., Vial, G., Jaussaud, R., Rouvière, B., Jeandel, P., Guffroy, A., Korganow, A., Jouvray, M., Meyer, A., Chatelus, E., Sordet, C., Felten, R., Sibilia, J., Litim-Ahmed-Yahia, S., Kleinmann, J., & Mariette, X. (2022). tolerance and efficacy of targeted therapies prescribed for off-label indications in refractory systemic autoimmune diseases: data of the first 100 patients enrolled in the TATA registry (TArgeted Therapy in Autoimmune Diseases). RMD open, 8(2), . http://access.bl.uk/ark:/81055/vdc_100168596713.0x000007